These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7987974)

  • 21. Plasma metabolomic profiles of breast cancer patients after short-term limonene intervention.
    Miller JA; Pappan K; Thompson PA; Want EJ; Siskos AP; Keun HC; Wulff J; Hu C; Lang JE; Chow HH
    Cancer Prev Res (Phila); 2015 Jan; 8(1):86-93. PubMed ID: 25388013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemoprevention and therapy of cancer by d-limonene.
    Crowell PL; Gould MN
    Crit Rev Oncog; 1994; 5(1):1-22. PubMed ID: 7948106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective inhibition of isoprenylation of 21-26-kDa proteins by the anticarcinogen d-limonene and its metabolites.
    Crowell PL; Chang RR; Ren ZB; Elson CE; Gould MN
    J Biol Chem; 1991 Sep; 266(26):17679-85. PubMed ID: 1894647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of combined limonene and 4-hydroxyandrostenedione in the treatment of NMU-induced rat mammary tumours.
    Chander SK; Lansdown AG; Luqmani YA; Gomm JJ; Coope RC; Gould N; Coombes RC
    Br J Cancer; 1994 May; 69(5):879-82. PubMed ID: 8180018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of d-limonene in adipose tissue by gas chromatography-mass spectrometry.
    Miller JA; Hakim IA; Thomson C; Thompson P; Chow HH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(1):68-73. PubMed ID: 18571481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adipose tissue accumulation of d-limonene with the consumption of a lemonade preparation rich in d-limonene content.
    Miller JA; Hakim IA; Chew W; Thompson P; Thomson CA; Chow HH
    Nutr Cancer; 2010; 62(6):783-8. PubMed ID: 20661827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk assessment of d-limonene: an example of male rat-specific renal tumorigens.
    Hard GC; Whysner J
    Crit Rev Toxicol; 1994; 24(3):231-54. PubMed ID: 7945892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro comparative analysis of antiproliferative activity of essential oil from mandarin peel and its principal component limonene.
    Manassero CA; Girotti JR; Mijailovsky S; García de Bravo M; Polo M
    Nat Prod Res; 2013; 27(16):1475-8. PubMed ID: 22943501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of farnesyl protein transferase and P21ras memebrane association by d-limonene in human pancreas tumor cells in vitro.
    Chen X; Yano Y; Hasuma T; Yoshimata T; Yinna W; Otani S
    Chin Med Sci J; 1999 Sep; 14(3):138-44. PubMed ID: 12903812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety evaluation and risk assessment of d-Limonene.
    Kim YW; Kim MJ; Chung BY; Bang du Y; Lim SK; Choi SM; Lim DS; Cho MC; Yoon K; Kim HS; Kim KB; Kim YS; Kwack SJ; Lee BM
    J Toxicol Environ Health B Crit Rev; 2013; 16(1):17-38. PubMed ID: 23573938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on the metabolism of d-limonene (p-mentha-1,8-diene). IV. Isolation and characterization of new metabolites and species differences in metabolism.
    Kodama R; Yano T; Furukawa K; Noda K; Ide H
    Xenobiotica; 1976 Jun; 6(6):377-89. PubMed ID: 969565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of orange oil on the oral absorption of enrofloxacin in rats.
    Lim JH; Kim MS; Hwang YH; Song IB; Kim TW; Yun HI
    Exp Anim; 2012; 61(1):71-5. PubMed ID: 22293675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral administration of d-limonene controls inflammation in rat colitis and displays anti-inflammatory properties as diet supplementation in humans.
    d'Alessio PA; Ostan R; Bisson JF; Schulzke JD; Ursini MV; Béné MC
    Life Sci; 2013 Jul; 92(24-26):1151-6. PubMed ID: 23665426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regression of rat primary mammary tumors following dietary d-limonene.
    Elegbede JA; Elson CE; Tanner MA; Qureshi A; Gould MN
    J Natl Cancer Inst; 1986 Feb; 76(2):323-5. PubMed ID: 3080636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. D-Limonene: safety and clinical applications.
    Sun J
    Altern Med Rev; 2007 Sep; 12(3):259-64. PubMed ID: 18072821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Limonene-induced regression of mammary carcinomas.
    Haag JD; Lindstrom MJ; Gould MN
    Cancer Res; 1992 Jul; 52(14):4021-6. PubMed ID: 1617679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Citrus peel use is associated with reduced risk of squamous cell carcinoma of the skin.
    Hakim IA; Harris RB; Ritenbaugh C
    Nutr Cancer; 2000; 37(2):161-8. PubMed ID: 11142088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo evaluation of limonene-based transdermal therapeutic system of nicorandil in healthy human volunteers.
    Krishnaiah YS; Chandrasekhar DV; Rama B; Jayaram B; Satyanarayana V; Al-Saidan SM
    Skin Pharmacol Physiol; 2005; 18(6):263-72. PubMed ID: 16113596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biotransformation of (R)-(+)- and (S)-(-)-limonene by fungi and the use of solid phase microextraction for screening.
    Demyttenaere JC; Van Belleghem K; De Kimpe N
    Phytochemistry; 2001 May; 57(2):199-208. PubMed ID: 11382235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of D-limonene on immune response in BALB/c mice with lymphoma.
    Del Toro-Arreola S; Flores-Torales E; Torres-Lozano C; Del Toro-Arreola A; Tostado-Pelayo K; Guadalupe Ramirez-Dueñas M; Daneri-Navarro A
    Int Immunopharmacol; 2005 May; 5(5):829-38. PubMed ID: 15778119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.